SAN GERONIMO, Calif., May 26, 2011 (GLOBE NEWSWIRE) -- T3, a subsidiary of Virogen, Inc. (Pink Sheets:VRNI), a technology holding company, today announced that the Company has developed a two part marketing strategy that consists of directly approaching Fortune 500 and other large enterprises that could benefit from their unique data security and tracking solutions as well as pursuing licensing opportunities with major software providers such as Microsoft and Oracle.
T3 has developed a very unique suite of copyrighted tools to address the network and database security needs of enterprise level companies and corporations. T3's risk management offering provides an unprecedented level of security and liability protection, positioning it as the only company with a comprehensive solution to data security breaches for its clients.
The Company's management believes that in order to maximize its success, T3 must explore opportunities to integrate its data security solutions with existing software platforms using a licensing model to generate revenue in addition to marketing its products directly to its target market.
Paul Hogan, CEO of Virogen, commented, "In addition to marketing our data security solutions directly to large enterprises and corporations, T3 will also pursue licensing opportunities with large software providers that could add value to their products by integrating our tools. We believe our Auditrac solution will especially be of great interest to these software providers because of its unique ability to track and store emails, files and data transmissions with complete accuracy, providing CFO's with peace of mind that in the event of any security breach and litigation, their information is retrievable and accurate."
About Virogen, Inc.
Virogen, Inc. is a technology holding company. The company's wholly owned subsidiary, Tiger Team Technologies "T3"'s risk management offering provides an unprecedented level of security and liability protection, positioning it as the only company with a comprehensive solution to data security breaches for its clients. T3's primary markets include medical service providers, financial services firms, brokerages and currency transaction platforms, consumer credit card companies, banking entities, retailers, defense and government related operations.
Forward-Looking Statements:
This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of Virogen, Inc. and members of its management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. The Company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions the occurrence of unanticipated events or changes to future operating results.